Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.AEAEROVATE THERAPEUTICS INC
Showing 4 of 17 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in AEROVATE THERAPEUTICS INC
As of its Q1 2025 13F, RA Capital Management held 9,192,092 shares of AEROVATE THERAPEUTICS, worth $23.1M. RA Capital Management's 13F filings listed AEROVATE THERAPEUTICS from Q2 2021 to Q1 2025, 16 quarterly filings. AEROVATE THERAPEUTICS was 0.4% of RA Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$19.2M
Total Shares Change
-9.2M
Quarter-by-Quarter History